Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Clinical Cancer Research|2018Cited by 95
Abstract A184: T-cell rejuvenation is associated with vorinostat-induced immune response in combination with immune checkpoint blockadeNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Cancer Immunology Research|2019Cited by 0
Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Ashley Orillion et al.|Unknown|2018Cited by 0
Supplementary Fig. 2 from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, George M. Yousef et al.|Unknown|2023Cited by 0
Supplementary Fig. 8 from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Unknown|2023Cited by 0